FRI-269 - Effectiveness, safety and quality of life in patients treated with Ombitasvir/Paritaprevir/r ± Dasabuvir ± Ribavirin under real-life conditions – data from the German observational study LIFE-C

Autor: Buggisch, P., Naumann, U., Link, R., Antoni, C., Teuber, G., Huelsenbeck, J., Lohmann, K., Kraus, M.R.
Zdroj: In Journal of Hepatology 2017 66(1) Supplement:S530-S530
Databáze: ScienceDirect
Externí odkaz: